Phase I/II clinical trial of comparison between carbon-ion therapy and proton therapy for primary tumors

Phase I/II clinical trial of comparison between carbon-ion therapy and proton therapy for primary tumors - Phase I/II clinical trial of comparison between carbon-ion therapy and proton therapy for primary tumors

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002132

Enrollment

396

Registered

2009-06-29

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary malignant tumors

Interventions

Carbon-ion therapy Proton therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Primary tumors of the head and neck, lung, liver, and bone and soft tissue eligible for the inclusion criteria and ineligible for the exclusion criteria of Hyogo Ion Beam Medical Center 2) 20 years old or older 3) Can be treated by either carbon-ion therapy or proton therapy 4) Expected to survive for 6 months or greater 5) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Pregnant, possible to be pregnant, or lactating 2) Judged to have difficulty being enrolled in the trial due to mental disorder 3) Can not meet the dose constraint of organs at risk in treatment planning

Design outcomes

Primary

Measure	Time frame
Local control rate	—

Secondary

Measure	Time frame
Late adverse effects	—

Countries

Japan

Contacts

Public ContactYusuke Demizu

Hyogo Ion Beam Medical Center Department of Radiology

y.demizu@hibmc.shingu.hyogo.jp0791-58-1315

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026